Skip to main content

Advertisement

SpringerLink
Log in

Mycobacterium Tuberculosis, Autoimmunity, and Vitamin D

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Mycobacterium tuberculosis (TB) is a major cause of morbidity and mortality worldwide. Current anti-TB chemotherapies, although effective, are associated with side effects and are limited in treating drug-resistant strands. Autoimmune diseases are a leading cause of morbidity and mortality, with a growing mass of evidence implicating infections (e.g., TB) as their triggers. The burden of TB might further increase by reactivation threats hovering over millions harboring latent infection, thus, calling for novel approaches for this dire ailment. In recent years, the non-calcemic physiological actions of vitamin D have drawn a great deal of attention. In this review, we will focus on the role of vitamin D in the innate immune defense against TB on the one hand and conversely on the immunomodulatory effects of vitamin D on autoimmunity. Taken together, the suggested dual role of vitamin D in treating TB infection and possibly preventing associated autoimmunity will constitute the basis of the current review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Koch R (1882) Die aetiologie der tuberculose. Berl Klinische Wochenschr 19:221–230

    Google Scholar 

  2. Mathema B, Kurepina N, Bifani P, Kreiswirth B (2006) Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 19:658–685

    CAS  PubMed  Google Scholar 

  3. Maartens G, Wilkinson R (2007) Tuberculosis. Lancet 370:2030–2043

    PubMed  Google Scholar 

  4. WHO (2008) Global tuberculosis control: surveillance, planning, financing: WHO report. WHO, Geneva WHO/HTM/TB/2008.393

    Google Scholar 

  5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M (1999) Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country [consensus statement]. WHO Global Surveillance and Monitoring Project. JAMA 282:677–686

    CAS  PubMed  Google Scholar 

  6. Comstock GW (1982) Epidemiology of tuberculosis. Am Rev Respir Dis 125:128

    Google Scholar 

  7. Iseman M, Madsen L (1989) Drug-resistant tuberculosis. Clin Chest Med 10:341–353

    CAS  PubMed  Google Scholar 

  8. WHO (2008) Anti-tuberculosis drug resistance in the world: WHO Fourth Global Report. WHO, Geneva WHO/HTM/TB/2008.394

    Google Scholar 

  9. Harel M, Shoenfeld Y (2006) Predicting and preventing autoimmunity, myth or reality? Ann NY Acad Sci 1069:322–345

    PubMed  Google Scholar 

  10. Shoenfeld Y, Isenberg DA (1989) The mosaic of autoimmunity. Immunol Today 10:123–126

    CAS  PubMed  Google Scholar 

  11. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin ME (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J 10:13–19

    PubMed  Google Scholar 

  12. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y (2008) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J 10:8–12

    PubMed  Google Scholar 

  13. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J 10:3–7

    PubMed  Google Scholar 

  14. Shoenfeld Y, Isenberg D (1988) Mycobacteria and autoimmunity. Immunol Today 9:178–182

    CAS  PubMed  Google Scholar 

  15. Elkayam O, Caspi D, Lidgi M, Segal R (2007) Auto-antibody profiles in patients with active pulmonary tuberculosis. Int j Tuberc Lung Dis 11:306–310

    CAS  PubMed  Google Scholar 

  16. Adams J, Hewison M (2008) Unexpected actions of vitamin-D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80–90

    CAS  PubMed  Google Scholar 

  17. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin-D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142

    CAS  PubMed  Google Scholar 

  18. Martineau A, Wilkinson R, Katalin A, Wilkinson R et al (2007) A single dose of vitamin-D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176:208–213

    CAS  PubMed  Google Scholar 

  19. Nursyam E, Amin Z, Rumende C (2006) The effect of vitamin-D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38:3–5

    PubMed  Google Scholar 

  20. Institute of Medicine (1997) Dietary reference intakes for calcium, magnesium, phosphorus, vitamin-D, and fluoride. National Academy, Washington, DC

    Google Scholar 

  21. Holick M (2007) Vitamin-D deficiency. N Engl J Med 357:266–281

    CAS  PubMed  Google Scholar 

  22. Gibney KB, MacGregor L, Leder K et al (2008) Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 46:443–446

    CAS  PubMed  Google Scholar 

  23. Holick M, Chen T (2008) Vitamin-D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086S

    CAS  PubMed  Google Scholar 

  24. Holick M (2008) Deficiency of sunlight and vitamin-D. BMJ 336:1318–1319

    PubMed  Google Scholar 

  25. Zittermann A (2003) Vitamin-D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552–572

    CAS  PubMed  Google Scholar 

  26. Strachan D, Powell K, Thaker A, Millard F, Maxwell J (1995) Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax 50:175–180

    CAS  PubMed  Google Scholar 

  27. Nnoaham K, Clarke A (2008) Low serum vitamin-D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113–119

    PubMed  Google Scholar 

  28. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn H (2007) Reactivation of tuberculosis and vitamin-D deficiency: the contribution of diet and exposure to sunlight. Thorax 62:1003–1007

    CAS  PubMed  Google Scholar 

  29. Bellamy R, Ruwende C, Corrah T, McAdam K et al (1999) Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin-D receptor gene. J Infect Dis 179:721–724

    CAS  PubMed  Google Scholar 

  30. Selvaraj P, Chandra G, Kurian S, Reetha A, Narayanan P (2003) Association of vitamin-D receptor gene variants of Bsm I, Apa I and Fok I polymorphisms with susceptibility or resistance to pulmonary tuberculosis. Curr Sci 84:1564–1568

    CAS  Google Scholar 

  31. Bornman L, Campbell S, Fielding K et al (2004) Vitamin-D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 190:1631–1641

    CAS  PubMed  Google Scholar 

  32. Wilbur A, Kubatko L, Hurtado A, Hill K (2007) Stone A. Vitamin-D receptor gene polymorphisms and susceptibility M. tuberculosis in Native Paraguayans. Tuberculosis 87:329–337

    CAS  PubMed  Google Scholar 

  33. Lewis S, Baker I, Davey S (2005) Meta-analysis of vitamin-D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis. 9:1174–1177

    CAS  PubMed  Google Scholar 

  34. Wilkinson R, Llewelyn M, Toossi Z, Patel P et al (2000) Influence of vitamin-D deficiency and vitamin-D receptor polymorphisms on susceptibility to tuberculosis amongst Gujarati Asians in west London: a case-control study. Lancet 355:618–621

    CAS  PubMed  Google Scholar 

  35. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Narayanan P (2008) Regulatory region polymorphisms of vitamin-D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south India. Int J Immunogenetics 35:251–254

    CAS  Google Scholar 

  36. Ralph A, Kelly P, Anstey N (2008) L-arginine and vitamin-D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol 16(7):336–344

    CAS  PubMed  Google Scholar 

  37. Williams CJB (1849) Cod liver oil in phthisis. London J Med 1:1–18

    Google Scholar 

  38. Charpy J (1950) Quelques traitments vitamin´es ou par substances fonctionelles en dermatologie. Bull M´ed 24:505

    Google Scholar 

  39. Martineau A, Honecker F, Wilkinson R, Griffiths C (2007) Vitamin-D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 103:793–798

    CAS  PubMed  Google Scholar 

  40. Liu P, Krutzik S, Modlin R (2007) Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 13:117–124

    PubMed  Google Scholar 

  41. Cosma C, Sherman D, Ramakrishnan L (2003) The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57:641–676

    CAS  PubMed  Google Scholar 

  42. Rook G, Steele J, Fraher L et al (1986) Vitamin-D3, γ interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159–163

    CAS  PubMed  Google Scholar 

  43. Crowle A, Ross E, May M (1987) Inhibition by 1, 25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 55:2945–2950

    CAS  PubMed  Google Scholar 

  44. Liu P, Stenger S, Wenzel H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773

    CAS  PubMed  Google Scholar 

  45. Adams J (2006) Vitamin-D as a defensin. J Musculoskelet Neuronal Interact 6:344–346

    CAS  PubMed  Google Scholar 

  46. Martineau A, Wilkinson K, Newton S et al (2007) IFN-γ- and TNF-independent vitamin-D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190–7198

    CAS  PubMed  Google Scholar 

  47. Liu P, Stenger S, Tang D, Modli R (2007) Cutting edge: Vitamin-D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060–2063

    CAS  PubMed  Google Scholar 

  48. Brightbill H, Libraty D, Krutzik S et al (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732–736

    CAS  PubMed  Google Scholar 

  49. Centers for Disease Control and Prevention (CDC) (2007) Trends in tuberculosis—United States. MMWR Morb Mortal Wkly Rep 57:281–285 2008

    Google Scholar 

  50. Ferrari G, Langen H, Naito M, Pieters J (1999) A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97:435–447

    CAS  PubMed  Google Scholar 

  51. Pieters J (2001) Evasion of host cell defense mechanisms by pathogenic bacteria. Curr Opin Immunol 13:37–44

    CAS  PubMed  Google Scholar 

  52. Anand P, Kaul D (2003) Vitamin-D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 310:876–877

    CAS  PubMed  Google Scholar 

  53. Anand P, Kaul D, Sharma M (2008) Synergistic action of vitamin-D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect 41:17–25

    CAS  PubMed  Google Scholar 

  54. Watts H, Lifeso R (1996) Tuberculosis of bones and joints. J Bone Joint Surg Am 78:288–298

    CAS  PubMed  Google Scholar 

  55. Hugosson C, Nyman R, Brismar J et al (1996) Imaging of tuberculosis. Peripheral osteoarticular and soft tissue tuberculosis. Acta Radiol 37:512–516

    CAS  PubMed  Google Scholar 

  56. Franco-Paredes C, Díaz-Borjon A, Senger M, Barragan L, Leonard M (2006) The ever-expanding association between rheumatologic diseases and tuberculosis. Am J Med 119:470–477

    PubMed  Google Scholar 

  57. Arthanari S, Yusuf S, Nisar M (2008) Tuberculosis of the knee complicating seronegative arthritis. J Rheumatol 35:1227–1228

    PubMed  Google Scholar 

  58. Kakourou T, Drosatou P, Psychou F, Aroni K, Nicolaidou P (2001) Erythema nodosum in children: a prospective study. J Am Acad Dermatol. 44:17–21

    CAS  PubMed  Google Scholar 

  59. Lowry K, Stephan K, Davis C (1999) Miliary tuberculosis presenting with rigors and developing unusual cutaneous manifestations. Cutis 64:23–28

    CAS  PubMed  Google Scholar 

  60. Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110–1112

    CAS  PubMed  Google Scholar 

  61. Teplizki H, Buskila D, Isenberg DA, Coates ARM, Sukenik S, Horowitz J, Shoenfeld Y (1987) Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507–511

    CAS  PubMed  Google Scholar 

  62. Zandman-Goddard G, Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38:473–485

    CAS  PubMed  Google Scholar 

  63. Shoenfeld Y, Schwartz R (1984) Immunologic and genetic factors in autoimmune diseases. N Eng J Med 311:1019–1029

    Article  CAS  Google Scholar 

  64. Blank M, Barzilai O, Shoenfeld Y (2007) Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32:111–118

    PubMed  Google Scholar 

  65. Doria A, Canova M, Tonon M, Zen M et al (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8:24–28

    CAS  PubMed  Google Scholar 

  66. Ortega-Hernandez OD, Agmon-Levin N, Blank M, Asherson RA, Shoenfeld Y (2009) The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. J Autoimmun 32:1–6

    CAS  PubMed  Google Scholar 

  67. Shoenfeld Y, Vilner Y, Coates A, Rauch J, Lavie G, Shaull D, Pinkhas J (1986) Monoclonal antituberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261

    CAS  PubMed  Google Scholar 

  68. Holoshitz J, Koning F, Coligan J et al (1989) Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 339:226–229

    CAS  PubMed  Google Scholar 

  69. Holoshitz J, Klajman A, Drucker I et al (1986) T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet 2:305–309

    CAS  PubMed  Google Scholar 

  70. Pope R, Wallis R, Sailer D et al (1991) T cell activation by mycobacterial antigens in inflammatory synovitis. Cell Immunol 133:95–108

    CAS  PubMed  Google Scholar 

  71. Haftel H, Chang Y, Hinderer R et al (1994) Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a microbacterial antigen. Clin Invet 94:1365–1372

    CAS  Google Scholar 

  72. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D (2000) Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res 86:1203–1210

    CAS  PubMed  Google Scholar 

  73. Winfield J (1989) Stress proteins, arthritis, and autoimmunity. Arthritis Rheum 32:1497–1504

    CAS  PubMed  Google Scholar 

  74. Jones D, Hunter N, Duff G (1990) Heat shock protein 65 as a β cell antigen of insulin dependent diabetes. Lancet 336:583–585

    CAS  PubMed  Google Scholar 

  75. Xu Q, Willeit J, Marosi M, Kleindienst R et al (1993) Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 341:255–259

    CAS  PubMed  Google Scholar 

  76. Perschinka H, Mayr M, Millonig G et al (2003) Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1060–1065

    CAS  PubMed  Google Scholar 

  77. Zhu J, Quyyumi A, Rott D et al (2001) Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 103:1071–1075

    CAS  PubMed  Google Scholar 

  78. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic Y, Wick G, Harats D (1999) Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein 65. Arterioscler Thromb Vasc Biol 19:505–510

    CAS  PubMed  Google Scholar 

  79. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J (2002) Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic esions. JACC 40:1333–1338

    CAS  PubMed  Google Scholar 

  80. Res P, Schaar C, Breedveld F et al (1988) Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 27:478–480

    Google Scholar 

  81. Tasneem S, Islam N, Ali R (2001) Crossreactivity of SLE autoantibodies with 70 kDa heat shock proteins of Mycobacterium tuberculosis. Microbiol Immunol 45:841–846

    CAS  PubMed  Google Scholar 

  82. Salvetti M, Buttinelli C, Ristori G et al (1992) T lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kD heat shock proteins in multiple sclerosis. J Autoimmun 5:691–702

    CAS  PubMed  Google Scholar 

  83. Salvetti M, Ristori G, Buttinelli C et al (1996) The immune response to mycobacterial 70 kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J Neuroimmunol 65:143–153

    CAS  PubMed  Google Scholar 

  84. Alard J, Dueymes M, Youinou P, Jamin C (2007) Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 6:438–443

    CAS  PubMed  Google Scholar 

  85. Gilbertson B, Germano S, Steele P et al (2004) Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. Infect Immun 72:6884–6891

    CAS  PubMed  Google Scholar 

  86. Salgame P (2005) Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol 17:374–380

    CAS  PubMed  Google Scholar 

  87. Baccala R, Kono D, Theofilopoulos A (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9–26

    CAS  PubMed  Google Scholar 

  88. Gardam M, Keystone E, Menzies R et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148–155

    CAS  PubMed  Google Scholar 

  89. Keane J, Gershon S, Wise R et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104

    CAS  PubMed  Google Scholar 

  90. Tincani A, Andreoli L, Bazzani C, Bosiso D, Sozzani S (2007) Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev 7:1–7

    CAS  PubMed  Google Scholar 

  91. Leadbetter E, Rifkin A, Hohlbaum A, Beaudette B et al (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607

    CAS  PubMed  Google Scholar 

  92. Rifkin I, Leadbetter E, Busconi L, Viglianti G, Marshak-Rothstein A (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27–42

    CAS  PubMed  Google Scholar 

  93. Eriksson U et al (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9:1484–1490

    CAS  PubMed  Google Scholar 

  94. Waldner H, Collins M, Kuchroo V (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113:990–997

    CAS  PubMed  Google Scholar 

  95. Deng G, Nilsson I, Verdrengh M et al (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5:702–705

    CAS  PubMed  Google Scholar 

  96. Segal B, Chang J, Shevach E (2000) CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J Immunol 164:5683–5688

    CAS  PubMed  Google Scholar 

  97. Lang K, Recher M, Junt T et al (2005) Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11:138–145

    CAS  PubMed  Google Scholar 

  98. Nishikubo K, Imanaka-Yoshida K, Tamaki S et al (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29:146–153

    CAS  PubMed  Google Scholar 

  99. Silver K, Crockford T, Bouriez-Jones T et al (2007) MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur J Immunol 37:2734–2743

    CAS  PubMed  Google Scholar 

  100. Sadanaga A, Nakashima H, Akahoshi M et al (2007) Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 56:1618–1628

    CAS  PubMed  Google Scholar 

  101. Mansell A, Brint E, Gould J et al (2004) Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4. J Biol Chem 279:37227–37230

    CAS  PubMed  Google Scholar 

  102. Reiling N, Holscher C, Fehrenbach A et al (2002) Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169:3480–3484

    CAS  PubMed  Google Scholar 

  103. Castiblanco J, Varela D, Castaño-Rodríguez N, Rojas-Villarraga A, Hincapié M, Anaya J (2008) TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol 8:541–544

    CAS  PubMed  Google Scholar 

  104. Pearson C (1956) Development of arthritis, periarthritis, and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 91:95–101

    CAS  PubMed  Google Scholar 

  105. Holoshitz J, Matitiahu A, Cohen I (1984) Arthritis induced in rats by cloned T-lymphocytes responsive to mycobacteria but not to collagen type II. J clin Invest 73:211–215

    CAS  PubMed  Google Scholar 

  106. Torisu M, Miyahara T, Shinohara N et al (1978) A new side effect of BCG immunotherapy: BCG-induced arthritis in man. Cancer Immunol Immunother 5:77–83

    Google Scholar 

  107. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin-D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385–400

    CAS  PubMed  Google Scholar 

  108. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin-D, vitamin-D in SLE: preliminary results. Ann N Y Acad Sci 1109:550–557

    CAS  PubMed  Google Scholar 

  109. Cantorna M, Zhu Y, Froicu M, Wittke A (2004) Vitamin-D status, 1, 25-dihydroxyvitamin-D3, and the immune system. Am J Clin Nutr 80:1717S–1720S

    CAS  PubMed  Google Scholar 

  110. Ponsonby A-L, McMichael A, van der Mei I (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181–182:71–78

    PubMed  Google Scholar 

  111. Pappa H, Gordon C, Saslowsky T et al (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961

    PubMed  Google Scholar 

  112. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin-D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692

    CAS  PubMed  Google Scholar 

  113. Aguado P, del Campo M, Garces M et al (2000) Low vitamin-D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739–744

    CAS  PubMed  Google Scholar 

  114. Kamen D, Cooper G, Bouali H et al (2006) Vitamin-D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117

    CAS  PubMed  Google Scholar 

  115. Munger K, Levin L, Hollis B, Howard N, Ascherio A (2006) Serum 25-hydroxyvitamin-D levels and risk of multiple sclerosis. JAMA 296:2832–2838

    CAS  PubMed  Google Scholar 

  116. Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y (1990) Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin-D3. J Nutr Sci Vitaminol 36:21–31

    CAS  PubMed  Google Scholar 

  117. Daniel C, Radeke H, Sartory N et al (2006) The new low calcemic vitamin-D analog 22-ene-25-oxa-vitamin-D prominently ameliorates Th1-mediated colitis in mice. J Pharmacol Exp Ther 319:622–631

    CAS  PubMed  Google Scholar 

  118. Cantorna M, Hayes C, DeLuca H (1996) 1, 25-Dihydroxyvitamin-D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861–8764

    CAS  PubMed  Google Scholar 

  119. Cantorna M, Humpal-Winter J, DeLuca H (1999) Dietary calcium is a major factor in 1, 25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129:1966–1971

    CAS  PubMed  Google Scholar 

  120. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin-D3. Diabetologia 37:552–558

    CAS  PubMed  Google Scholar 

  121. Munger K, Zhang S, O'Reilly E et al (2004) Vitamin-D intake and incidence of multiple sclerosis. Neurology 62:60–65

    CAS  PubMed  Google Scholar 

  122. Merlino L, Curtis J, Mikuls T et al (2004) Vitamin-D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72–77

    CAS  PubMed  Google Scholar 

  123. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7:59–64

    CAS  PubMed  Google Scholar 

  124. Goldberg P, Fleming M, Picard E (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin-D. Med Hypotheses 21:193–200

    CAS  PubMed  Google Scholar 

  125. Birlea S, Costin G, Norris D (2008) Cellular and molecular mechanisms involved in the action of vitamin-D analogs targeting vitiligo depigmentation. Curr Drug Targets 9:345–359

    CAS  PubMed  Google Scholar 

  126. Hypponen E, Laara E, Reunanen A, Jarvelin M, Virtanen S (2001) Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 358:1500–1503

    CAS  PubMed  Google Scholar 

  127. Bhalla A, Amento E, Clemens T et al (1983) Specific high-affinity receptors for 1, 25-dihydroxyvitamin-D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308–1310

    CAS  PubMed  Google Scholar 

  128. Provvedini D, Tsoukas C, Deftos L, Manolagas S (1986) 1 alpha, 25-Dihydroxyvitamin-D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol 136:2734–2740

    CAS  PubMed  Google Scholar 

  129. Chen S, Sims GP, Chen X et al (2007) Modulatory effects of 1, 25-dihydroxyvitamin-D3 on human B cell differentiation. J Immunol 179:1634–1647

    CAS  PubMed  Google Scholar 

  130. Doria A, Arienti S, Rampudda M, Canova M et al (2008) Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 7:192–197

    PubMed  Google Scholar 

  131. Overbergh L, Decallonne B, Waer M et al (2000) 1alpha, 25-dihydroxyvitamin-D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543). Diabetes 49:1301–1307

    CAS  PubMed  Google Scholar 

  132. Bhalla A, Amento E, Serog B, Glimcher L (1984) 1, 25-Dihydroxyvitamin-D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754

    CAS  PubMed  Google Scholar 

  133. Lemire J (1992) Immunomodulatory role of 1, 25-dihydroxyvitamin-D3. J Cell Biochem 49:26–31

    CAS  PubMed  Google Scholar 

  134. Lemire J, Archer D, Beck L, Spiegelberg H (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin-D3: preferential inhibition of Th1 functions. J Nutr 125:1704S–1708S

    CAS  PubMed  Google Scholar 

  135. van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin-D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101

    PubMed  Google Scholar 

  136. Ramos-Lopez E, Jansen T, Ivaskevicius V et al (2006) Protection from type 1 diabetes by vitamin-D receptor haplotypes. Ann N Y Acad Sci 1079:327–334

    CAS  PubMed  Google Scholar 

  137. Bailey R, Cooper J, Zeitels L et al (2007) Association of the vitamin-D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616–2621

    CAS  PubMed  Google Scholar 

  138. Huang C, Wu M, Wu J, Tsai F (2002) Association of vitamin-D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11:31–34

    CAS  PubMed  Google Scholar 

  139. Shimada A, Kanazawa Y, Motohashi Y et al (2008) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 30:207–211

    CAS  PubMed  Google Scholar 

  140. Penna G, Amuchastegui S, Cossetti C et al (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin-D receptor agonist elocalcitol. J Immunol 177:8504–8511

    CAS  PubMed  Google Scholar 

  141. Penna G, Adorini L (2000) 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411

    CAS  PubMed  Google Scholar 

  142. Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127–134

    CAS  PubMed  Google Scholar 

  143. Luciano A, Giuseppe P (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412

    Google Scholar 

  144. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemilogy, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325–30

    PubMed  Google Scholar 

  145. Adebajo A, Charles P, Maini R, Hazleman B (1993) Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol 92:73–76

    CAS  PubMed  Google Scholar 

  146. Flores-Suarez LF, Cabiedes J, Villa AR, van der Woude FJ, Alcocer-Varela J (2003) Prevalence of antineutrophilic cytoplasmatic autoantibodies in patients with tuberculosis. Rheumatology 42:223–229

    CAS  PubMed  Google Scholar 

  147. Sela O, el-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J, Shoenfeld Y (1987) A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50–56

    CAS  PubMed  Google Scholar 

  148. Isenberg D, Maddison P, Swana G (1987) Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other Gram-negative infections. Clin Exp Immunol 67:516–523

    CAS  PubMed  Google Scholar 

  149. Di Cesar D, Ploutz-Snyder R, Weinstock R, Moses A (2006) Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 29:174

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel

    Yinon Shapira, Nancy Agmon-Levin & Yehuda Shoenfeld

  2. Department of Medicine ‘B’, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel

    Nancy Agmon-Levin & Yehuda Shoenfeld

  3. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Yehuda Shoenfeld

Authors
  1. Yinon Shapira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy Agmon-Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Shoenfeld.

Additional information

This review utilized the PubMed database; references from relevant articles; and the WHO website for identification of relevant data. Key search terms included “tuberculosis,” “vitamin D,” “vitamin D deficiency,” “autoimmune disease,” “epidemiology,” and “innate immunity.” English language papers were reviewed.

Yehuda Schoenfield is an incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shapira, Y., Agmon-Levin, N. & Shoenfeld, Y. Mycobacterium Tuberculosis, Autoimmunity, and Vitamin D. Clinic Rev Allerg Immunol 38, 169–177 (2010). https://doi.org/10.1007/s12016-009-8150-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-009-8150-1

Keywords

Search

Navigation